US20110034518A1 - Pharmaceutical composition - Google Patents

Pharmaceutical composition Download PDF

Info

Publication number
US20110034518A1
US20110034518A1 US12/923,975 US92397510A US2011034518A1 US 20110034518 A1 US20110034518 A1 US 20110034518A1 US 92397510 A US92397510 A US 92397510A US 2011034518 A1 US2011034518 A1 US 2011034518A1
Authority
US
United States
Prior art keywords
group
enhancer
groups
insulin
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/923,975
Inventor
Hitoshi Ikeda
Takashi Sohda
Hiroyuki Odaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to JP153500/1995 priority Critical
Priority to JP15350095 priority
Priority to US08/667,979 priority patent/US5952356A/en
Priority to US09/057,465 priority patent/US5965584A/en
Priority to US09/280,710 priority patent/US6150383A/en
Priority to US09/453,521 priority patent/US6329404B1/en
Priority to US09/973,689 priority patent/US6384062B1/en
Priority to US10/095,453 priority patent/US6599923B2/en
Priority to US10/462,793 priority patent/US6911459B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15563926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110034518(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US10/937,494 priority patent/US7144900B2/en
Priority to US11/523,771 priority patent/US7538125B2/en
Priority to US12/382,691 priority patent/US7842706B2/en
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to US12/923,975 priority patent/US20110034518A1/en
Publication of US20110034518A1 publication Critical patent/US20110034518A1/en
Application status is Abandoned legal-status Critical

Links